UA100865C2 - Твердый дисперсный продукт лекарственных средств на основе n-арилмочевины - Google Patents
Твердый дисперсный продукт лекарственных средств на основе n-арилмочевиныInfo
- Publication number
- UA100865C2 UA100865C2 UAA201006029A UAA201006029A UA100865C2 UA 100865 C2 UA100865 C2 UA 100865C2 UA A201006029 A UAA201006029 A UA A201006029A UA A201006029 A UAA201006029 A UA A201006029A UA 100865 C2 UA100865 C2 UA 100865C2
- Authority
- UA
- Ukraine
- Prior art keywords
- heading
- solid dispersion
- dispersion product
- normal
- aryl urea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Твердый дисперсный продукт, который включает, по меньшей мере, одно фармацевтически активное вещество на основе N-арилмочевины, получают путем а) получения жидкой смеси, содержащей, по меньшей мере, одно активное вещество по меньшей мере одно фармацевтически приемлемое вещество, которое образовывает матрицу, по меньшей мере одно фармацевтически приемлемое поверхностно-активное вещество и по меньшей мере один растворитель, и b) удаления растворителя (растворителей) из жидкой смеси с получением твердого дисперсного продукта.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99961807P | 2007-10-19 | 2007-10-19 | |
PCT/EP2008/064076 WO2009050291A2 (en) | 2007-10-19 | 2008-10-17 | Solid dispersion product of n-aryl urea-based drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
UA100865C2 true UA100865C2 (ru) | 2013-02-11 |
Family
ID=40089463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201006029A UA100865C2 (ru) | 2007-10-19 | 2008-10-17 | Твердый дисперсный продукт лекарственных средств на основе n-арилмочевины |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2197425A2 (ru) |
JP (1) | JP2011500649A (ru) |
KR (1) | KR20100087170A (ru) |
CN (1) | CN101827584A (ru) |
AU (1) | AU2008313622A1 (ru) |
BR (1) | BRPI0818340A2 (ru) |
CA (1) | CA2699301A1 (ru) |
CO (1) | CO6270206A2 (ru) |
CR (1) | CR11442A (ru) |
DO (1) | DOP2010000117A (ru) |
EC (1) | ECSP10010183A (ru) |
GT (1) | GT201000102A (ru) |
MX (1) | MX2010004291A (ru) |
PA (1) | PA8800101A1 (ru) |
RU (1) | RU2010119929A (ru) |
UA (1) | UA100865C2 (ru) |
WO (1) | WO2009050291A2 (ru) |
ZA (1) | ZA201002095B (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090203709A1 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor |
JO3002B1 (ar) | 2009-08-28 | 2016-09-05 | Irm Llc | مركبات و تركيبات كمثبطات كيناز بروتين |
SG2014013502A (en) | 2010-06-09 | 2014-05-29 | Abbvie Inc | Solid dispersions containing kinase inhibitors |
JP6150813B2 (ja) | 2011-11-11 | 2017-06-21 | ノバルティス アーゲー | 増殖性疾患の治療方法 |
WO2013078264A1 (en) | 2011-11-23 | 2013-05-30 | Novartis Ag | Pharmaceutical formulations |
WO2014003677A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising solid dispersion particles containing tadalafil |
WO2014003678A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2626579A1 (en) * | 2005-10-25 | 2007-05-03 | Abbott Laboratories | Formulation comprising a drug of low water solubility and method of use thereof |
WO2007066189A2 (en) * | 2005-12-09 | 2007-06-14 | Pfizer Products Inc. | Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea |
AU2007316558A1 (en) * | 2006-11-09 | 2008-05-15 | Abbott Gmbh & Co. Kg | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
-
2008
- 2008-10-17 CN CN200880112150A patent/CN101827584A/zh active Pending
- 2008-10-17 PA PA20088800101A patent/PA8800101A1/es unknown
- 2008-10-17 RU RU2010119929/15A patent/RU2010119929A/ru not_active Application Discontinuation
- 2008-10-17 BR BRPI0818340 patent/BRPI0818340A2/pt not_active IP Right Cessation
- 2008-10-17 MX MX2010004291A patent/MX2010004291A/es not_active Application Discontinuation
- 2008-10-17 KR KR1020107010979A patent/KR20100087170A/ko not_active Application Discontinuation
- 2008-10-17 WO PCT/EP2008/064076 patent/WO2009050291A2/en active Application Filing
- 2008-10-17 AU AU2008313622A patent/AU2008313622A1/en not_active Abandoned
- 2008-10-17 JP JP2010529408A patent/JP2011500649A/ja active Pending
- 2008-10-17 EP EP08839333A patent/EP2197425A2/en not_active Withdrawn
- 2008-10-17 UA UAA201006029A patent/UA100865C2/ru unknown
- 2008-10-17 CA CA2699301A patent/CA2699301A1/en not_active Abandoned
-
2010
- 2010-03-24 ZA ZA2010/02095A patent/ZA201002095B/en unknown
- 2010-04-16 DO DO2010000117A patent/DOP2010000117A/es unknown
- 2010-04-16 GT GT201000102A patent/GT201000102A/es unknown
- 2010-04-27 CO CO10049271A patent/CO6270206A2/es not_active Application Discontinuation
- 2010-05-17 EC EC2010010183A patent/ECSP10010183A/es unknown
- 2010-05-19 CR CR11442A patent/CR11442A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA201002095B (en) | 2011-11-30 |
CR11442A (es) | 2010-09-06 |
PA8800101A1 (es) | 2009-05-15 |
CA2699301A1 (en) | 2009-04-23 |
RU2010119929A (ru) | 2011-11-27 |
BRPI0818340A2 (pt) | 2015-04-22 |
GT201000102A (es) | 2012-03-12 |
DOP2010000117A (es) | 2010-05-15 |
JP2011500649A (ja) | 2011-01-06 |
EP2197425A2 (en) | 2010-06-23 |
AU2008313622A1 (en) | 2009-04-23 |
KR20100087170A (ko) | 2010-08-03 |
CO6270206A2 (es) | 2011-04-20 |
MX2010004291A (es) | 2010-08-02 |
WO2009050291A2 (en) | 2009-04-23 |
CN101827584A (zh) | 2010-09-08 |
WO2009050291A3 (en) | 2010-04-08 |
ECSP10010183A (es) | 2010-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010004292A (es) | Producto de dispersion solida que contiene un compuesto a base de n-aril urea. | |
UA100865C2 (ru) | Твердый дисперсный продукт лекарственных средств на основе n-арилмочевины | |
TW200640502A (en) | Tablets with improved drug substance dispersibility | |
WO2006035417A3 (en) | Dihydropyrimidine microcapsule - formulations | |
TW200716202A (en) | Pediatric formulation of topiramate | |
ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
PL2046292T3 (pl) | Preparaty eterów benzymidazolilo-pirydylowych | |
WO2007086078A3 (en) | Novel pharmaceutical compositions and process of preparation thereof | |
WO2010015567A3 (en) | Controlled release formulations using intelligent polymers | |
WO2009082152A3 (en) | Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient | |
MX2009010675A (es) | Formulaciones farmaceuticas de moleculas de la hormona liberadora de la hormona delcrecimiento humana. | |
WO2009060952A1 (ja) | 新規製剤 | |
NZ602441A (en) | A fast dissolving pharmaceutical composition | |
WO2011076209A3 (en) | Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue | |
WO2006127321A3 (en) | Formulations of suberoylanilide hydroxamic acid and methods for producing same | |
WO2006110810A3 (en) | Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine | |
WO2007065625A3 (en) | Pharmaceutical compositions of short-acting hypnotic agents in modified-release forms and the procedures to prepare the mentioned formulations | |
WO2011058336A3 (en) | Tablet comprising gum arabic | |
WO2008084864A1 (ja) | カプサイシン受容体活性化剤及びそれを噴霧する装置 | |
WO2009008004A3 (en) | Sustained release formulations of divalproex sodium | |
WO2009043577A3 (de) | 19-nor-progesterone zur kontrazeption | |
WO2010058104A3 (fr) | Compositions pharmaceutiques utilisant l'inuline comme excipient de granulation | |
WO2008122425A3 (en) | Oral compositions containing tacrolimus in amorphous form | |
WO2008129607A1 (ja) | ヒアルロナン産生促進剤及びヒアルロナン分解抑制剤 | |
WO2008105392A1 (ja) | 3-アミノ-2-インドリルブチロラクタム誘導体、その製造法、及びこれを有効成分とする医薬 |